Document is current
Any future updates will be listed below
-
Authors
Teh, Muy-Teck https://orcid.org/0000-0002-7725-8355
Patil, Ranjitkumar
Tekade, Satyajit Ashok
Mishra, Deepika
Chaurasia, Akhilanand
Waseem, Ahmad
-
Funding
Funding for this research was provided by:
Queen Mary Innovation
BBSRC Queen Mary Impact Fund Award
Barts Centre for Squamous Cancer funded by Barts Charity (G-002030)
- License Information
-
More Information
Article History
Received: 16 February 2026
Accepted: 19 June 2026
First Online: 23 June 2026
Declarations
:
: The research protocol for our study was approved by the relevant Research Ethics Committee at each institution: Queen Mary University of London (UK NREC:06/MRE03/69 and QMERC20.142); King George’s Medical University, India (104th ECM IIA/P18) and the study was conducted in accordance with the Declaration of Helsinki. All clinical samples were collected according to approved protocol and informed consent was obtained from all participants.
: Not applicable.
: M.T.T. declared that patents have been filed by QM Innovation Ltd for the qMIDS technology (PCT/EP2020/070689, US20230133776 and GB2512759.8), covering its methodology and clinical applications. No disclosures were reported by the other authors.
